These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36330895)

  • 1. Intra-tumor heterogeneity and prognostic risk signature for hepatocellular carcinoma based on single-cell analysis.
    Liu C; Pu M; Ma Y; Wang C; Kong L; Zhang S; Zhao X; Lian X
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1741-1751. PubMed ID: 36330895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns.
    Wang C; Yang G; Feng G; Deng C; Zhang Q; Chen S
    Front Immunol; 2024; 15():1410603. PubMed ID: 39044829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing.
    Li H; Shi Y; Li Y; Wu S; Yang R; Liu Q; Sun L
    Int Immunopharmacol; 2024 Aug; 137():112475. PubMed ID: 38909498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
    Chen W; Yang Z; Chen Y
    Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing.
    Fan L; Xu L; Tian S; Zheng X
    Front Endocrinol (Lausanne); 2022; 13():965445. PubMed ID: 36120466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
    Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J
    Front Immunol; 2022; 13():994259. PubMed ID: 36341373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration.
    Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H
    Front Immunol; 2022; 13():1023349. PubMed ID: 36353638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma.
    Li D; Bao Q; Ren S; Ding H; Guo C; Gao K; Wan J; Wang Y; Zhu M; Xiong Y
    Genet Res (Camb); 2024; 2024():8217215. PubMed ID: 39297018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.